Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Commentary
  • Published:

Tipping the scales of herpes simplex virus reactivation: The important responses are local

Although the most severe Herpes Simplex Virus-related symptoms seem to occur in patients with impaired cell-mediated immunity, until recently it appeared that patients who seemed to better control the infection showed little by way of anti-HSV cytotoxic T lymphocyte responses. Lawrence Corey and colleagues explain.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Wald, A., Zeh, J., Selke, S., Ashley, R.L. & Corey, L. Virologic characteristics of sub-clinical and symptomatic genital herpes infections. N. Engl. J. Med. 333, 770–775 (1995).

    Article  CAS  PubMed  Google Scholar 

  2. Wald, A. et al. Frequent genital herpes simplex virus 2 shedding in immunocompetent women: effect of acyclovir treatment. J. Clin. Invest. 99,1092–97 (1997).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Schmid, D.S. & Rouse, B.T. The role of T cell immunity in control of herpes simplex virus. Cur. Top. Microbiol. Immunol. 179, 57–74 (1992).

    CAS  Google Scholar 

  4. Rinaldo, C.R., St Torpey, D.J. Cell-mediated immunity and immunosuppression in herpes simplex virus infection. Immunodef. 5, 33–90 (1993).

    Google Scholar 

  5. Schmid, D.S. The human MHC-restricted cellular response to herpes simplex virus type 1 is mediated by CD4+, CD8− T cells and is restricted to the DR region of the MHC complex. J. Immunol. 40, 3610–3616 (1988).

    Google Scholar 

  6. Carmack, M.A. et al. T cell recognition and cytokine production elicited by common and type-specific glycoproteins of herpes simplex virus type 1 and type 2. J. Inf. Dis. 174, 899–906 (1996).

    Article  CAS  Google Scholar 

  7. Koelle, D.M. et al. Antigenic specificities of human CD4+ T-cell clones recovered from recurrent genital herpes simplex virus type 2 lesions. J. Virol. 68, 2803–2810 (1994).

    CAS  PubMed  PubMed Central  Google Scholar 

  8. Koelle, D.M., Abbo, H., Peck, A., Ziegweid, K. & Corey, L. Direct recovery of herpes simplex virus (HSV)-specific T lymphocyte clones from recurrent genital HSV-2 lesions. J. Inf. Dis. 169, 956–961 (1994).

    Article  CAS  Google Scholar 

  9. Torpey, D.J., Lindsley, M.D. & Rinaldo, C.R. HLA-restricted lysis of herpes simplex virus-infected monocytes and macrophages mediated by CD4+ and CD8+ T lymphocytes. J. Immunol. 142, 1325–1332 (1989).

    PubMed  Google Scholar 

  10. Hill, A. et al. Herpes simplex virus turns off the TAP to evade host immunity. Nature 375, 411–415 (1995).

    Article  CAS  PubMed  Google Scholar 

  11. Tigges, M.A., Leng, S., Johnson, D.C. & Burke, R.L. Human herpes simplex virus (HSV)-specific CD8+ CTL clones recognize HSV-2-infected fibroblasts after treatment with IFN-γ or when virion host shutofffunctions are disabled. J. Immunol. 156, 3901–3910 (1996).

    CAS  PubMed  Google Scholar 

  12. Tigges, M.A. et al. Human CD8+ herpes simplex virus-specific cytotoxic T-lymphocyte clones recognize diverse virion protein antigens. J. Virol. 66,1622–1634 (1992).

    CAS  PubMed  PubMed Central  Google Scholar 

  13. Pasvad, C.M., Koelle, D.M. & Corey, L. High frequency of CD8+ cytotoxic T-lymphocyte precursors specific for herpes simplex viruses in persons with genital herpes. J. Virol. 70, 8165–8168 (1996).

    Google Scholar 

  14. Koelle, D.M. et al. Clearance of HSV-2 from recurrent genital lesions correlates with infiltration of HSV-specific cytotoxic T lymphocytes. J. Clin. Invest. In the Press.

  15. Koelle, D.M. et al. Herpes simplex virus infection of human fibroblasts and keratinocytes inhibits recognition by cloned CD8+ cytotoxic T lymphocytes. J. Clin. Invest. 91, 961–968 (1993).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Mikloska, Z., Kesson, A.M., Penfold, M.E.T. & Cunningham, A.L. Herpes simplex virus protein targets for CD4 and CD8 lymphocyte cytotoxicity in cultured epidermal keratinocytes treated with interferon-γ. J. Inf. Dis. 173, 7–17 (1996).

    Article  CAS  Google Scholar 

  17. Van Voorhis, W.C. et al. Primary and secondary syphilis lesions contain mRNA for Th1 cytokines. J. Inf. Dis. 173,491–5 (1996).

    Article  CAS  Google Scholar 

  18. Torseth, J.W. & Merigan, T.C. Significance of local γ interferon in recurrent herpes simplex infection. J. Inf. Dis. 153, 979–984 (1986).

    Article  CAS  Google Scholar 

  19. Boehm, U., Klamp, T.M. & Howard, J.C., Responses to Interferon-γ. Ann. Rev. Immunol. 15, 749–95 (1997).

    Article  CAS  Google Scholar 

  20. Posavad, C.M., Koelle, D.M., Shaughnessy, M.F. & Corey, L. Severe genital herpes infections in HIV-infected individuals with impaired HSV-specific CD8+ cytotoxic T lymphocyte activity. Proc. Natl. Acad. Sci. USA 94, 10289–10294 (1997).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Cunningham, A.L., Turner, R.R.,A.C.M., Para, M.F. & Merigan, T.C. Evolution of recurrent herpes simplex lesions: an immunohistologic study. J. Clin. Invest. 75,226–233 (1985).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Posavad, C., Koelle, D. & Corey, L. Tipping the scales of herpes simplex virus reactivation: The important responses are local. Nat Med 4, 381–382 (1998). https://doi.org/10.1038/nm0498-381

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm0498-381

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing